Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar
CEOGrowthProduct Portfolio
Launch marks Zentiva’s strategic entry into biosimilars and reinforces its mission to broaden patient access to high-quality biologic medicines across Europe.
Loading component...
Loading component...
Media contacts:


